Skip to main content

Advertisement

Log in

The role of the RTEL1 rs2297440 polymorphism in the risk of glioma development: a meta-analysis

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The regulator of the telomere elongation helicase1 (RTEL1) gene plays a crucial role in the DNA double-stand break-repair pathway by maintaining genomic stability. Recent epidemiological studies showed that the rs2297440 polymorphism in the RTEL1 gene was a potential risk locus for glioma development, but the results were inconclusive. To clarify the association between this polymorphism and the risk of glioma, we performed a comprehensive meta-analysis. The PubMed, EMBASE, Web of Science, and China National Knowledge Infrastructure databases were systematically searched to identify all relevant published studies up to 30 August 2015. Four eligible studies were finally included. The pooled results indicated that the RTEL1 rs2297440 polymorphism moderately increased the risk of glioma in all genetic models. A comparison of the dominant model CT + CC versus TT (OR 1.40; 95 % CI 1.24–1.60; p < 0.001) indicated that having the C allele conferred a 40 % increased risk of developing glioma. In a subgroup analysis based on geographic location (Europe, Asia, and America), there was an association between the rs2297440 polymorphism and the risk of glioma in all three areas. The results of the subgroup analysis based on source of control indicated an elevated risk of glioma in population-based control studies. This meta-analysis demonstrates that the RTEL1 rs2297440 polymorphism plays a moderate, but significant role in the risk of glioma. Further studies with larger sample sizes are necessary to confirm this finding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205:613–621. doi:10.1016/j.cancergen.2012.10.009

    Article  CAS  PubMed  Google Scholar 

  2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. doi:10.1007/s00401-007-0243-4

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25:867–890. doi:10.1016/j.ncl.2007.07.002

    Article  PubMed  Google Scholar 

  4. Zheng TZ, Cantor KP, Zhang YW, Chiu BCH, Lynch CF (2001) Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomark Prev 10:413–414

    CAS  Google Scholar 

  5. Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, Arslan A, Ahlbom A, Giles GG, Howe GR, Menegoz F, Rodvall Y, Choi WN, Wahrendorf J (2005) Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer 113:116–125. doi:10.1002/ijc.20504

    Article  CAS  PubMed  Google Scholar 

  6. Huncharek M, Kupelnick B, Wheeler L (2003) Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 22:129–137

    CAS  PubMed  Google Scholar 

  7. Hardell L, Carlberg M, Soderqvist F, Mild KH, Morgan LL (2007) Long-term use of cellular phones and brain tumours: increased risk associated with use for > or = 10 years. Occup Environ Med 64:626–632. doi:10.1136/oem.2006.029751

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kan P, Simonsen SE, Lyon JL, Kestle JRW (2008) Cellular phone use and brain tumor: a meta-analysis. J Neurooncol 86:71–78. doi:10.1007/s11060-007-9432-1

    Article  PubMed  Google Scholar 

  9. Hardell L, Carlberg M, Hansson Mild K (2009) Epidemiological evidence for an association between use of wireless phones and tumor diseases. Pathophysiology 16:113–122. doi:10.1016/j.pathophys.2009.01.003

    Article  PubMed  Google Scholar 

  10. Ostrom QT, Barnholtz-Sloan JS (2011) Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep 11:329–335. doi:10.1007/s11910-011-0189-8

    Article  PubMed  Google Scholar 

  11. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lonn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899–904. doi:10.1038/ng.407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O’Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905–908. doi:10.1038/ng.408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, LaRocca RV, Brem S, Moots PL, Madden MH, Browning JE, Chen YA (2011) Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 104:535–542. doi:10.1007/s11060-010-0506-0

    Article  PubMed  PubMed Central  Google Scholar 

  14. Polymorphismsafaeian M, Rajaraman P, Hartge P, Yeager M, Linet M, Butler MA, Ruder AM, Purdue MP, Hsing A, Beane-Freeman L, Hoppin JA, Albanes D, Weinstein SJ, Inskip PD, Brenner A, Rothman N, Chatterjee N, Gillanders EM, Chanock SJ, Wang SS (2013) Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control 24:1885–1891. doi:10.1007/s10552-013-0244-7

    Article  Google Scholar 

  15. Kruisselbrink E, Guryev V, Brouwer K, Pontier DB, Cuppen E, Tijsterman M (2008) Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C-elegans. Curr Biol 18:900–905. doi:10.1016/j.cub.2008.05.013

    Article  CAS  PubMed  Google Scholar 

  16. Paeschke K, Capra JA, Zakian VA (2011) DNA replication through G-Quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell 145:678–691. doi:10.1016/j.cell.2011.04.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ding H, Schertzer M, Wu XL, Gertsenstein M, Selig S, Kammori M, Pourvali R, Poon S, Vulto I, Chavez E, Tam PPL, Nagy A, Lansdorp PM (2004) Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117:873–886. doi:10.1016/j.cell.2004.05.026

    Article  CAS  PubMed  Google Scholar 

  18. Uringa EJ, Lisaingo K, Pickett HA, Brind’Amour J, Rohde JH, Zelensky A, Essers J, Lansdorp PM (2012) RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol Biol Cell 23:2782–2792. doi:10.1091/mbc.E12-03-0179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Vannier JB, Sandhu S, Petalcorin MIR, Wu XL, Nabi Z, Ding H, Boulton SJ (2013) RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. Science 342:239–242. doi:10.1126/science.1241779

    Article  CAS  PubMed  Google Scholar 

  20. Muleris M, Almeida A, Gerbaultseureau M, Malfoy B, Dutrillaux B (1995) Identification of amplified DNA-sequences in breast-cancer and their organization within homogeneously staining regions. Genes Chromosome Cancer 14:155–163. doi:10.1002/gcc.2870140302

    Article  CAS  Google Scholar 

  21. Bai C, Connolly B, Metzker ML, Hilliard CA, Liu X, Sandig V, Soderman A, Galloway SM, Liu Q, Austin CP, Caskey CT (2000) Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 97:1230–1235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Wu X, Sandhu S, Nabi Z, Ding H (2012) Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis. Transgenic Res 21:1109–1115. doi:10.1007/s11248-011-9586-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, Lathrop M, Liu C, Le Marchand L, Linet MS, Lonn S, Peters U, Purdue MP, Rothman N, Ruder AM, Sanson M, Sesso HD, Severi G, Shu XO, Simon M, Stampfer M, Stevens VL, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Decker P, Enciso-Mora V, Fridley B, Gao YT, Kosel M, Lachance DH, Lau C, Rice T, Swerdlow A, Wiemels JL, Wiencke JK, Shete S, Xiang YB, Xiao Y, Hoover RN, Fraumeni JF Jr, Chatterjee N, Hartge P, Chanock SJ (2012) Genome-wide association study of glioma and meta-analysis. Hum Genet 131:1877–1888. doi:10.1007/s00439-012-1212-0

    Article  PubMed  PubMed Central  Google Scholar 

  24. Adel Fahmideh M, Lavebratt C, Schuz J, Roosli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M (2015) CCDC26, CDKN2BAS, RTEL1 and TERT polymorphisms in pediatric brain tumor susceptibility. Carcinogenesis 36:876–882. doi:10.1093/carcin/bgv074

    Article  PubMed  Google Scholar 

  25. Gallus GN, Cardaioli E, Rufa A, Da Pozzo P, Bianchi S, D’Eramo C, Collura M, Tumino M, Pavone L, Federico A (2010) Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy. Mol Vis 16:178–183

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Vannier JB, Sarek G, Boulton SJ (2014) RTEL1: functions of a disease-associated helicase. Trends Cell Biol 24:416–425. doi:10.1016/j.tcb.2014.01.004

    Article  CAS  PubMed  Google Scholar 

  27. Wei X-B, Jin T-B, Li G, Geng T-T, Zhang J-Y, Chen C-P, Gao G-D, Chen C, Gong Y-K (2014) CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population. Asian Pac J Cancer Prev 15:3629–3633. doi:10.7314/apjcp.2014.15.8.3629

    Article  PubMed  Google Scholar 

  28. T Cui (2015) CCDC26 rs4295627 polymorphism and glioma risk. Int J Clin Exp Med 8(3):3862–3868

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Lau J, Ioannidis JPA, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826

    Article  CAS  PubMed  Google Scholar 

  30. Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. doi:10.1002/sim.1186

    Article  PubMed  Google Scholar 

  31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  32. Zhao W, Bian Y, Zhu W, Zou P, Tang G (2014) Regulator of telomere elongation helicase 1 (RTEL1) rs6010620 polymorphism contribute to increased risk of glioma. Tumour Biol 35:5259–5266. doi:10.1007/s13277-014-1684-8

    Article  CAS  PubMed  Google Scholar 

  33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  CAS  PubMed  Google Scholar 

  35. Li G, Jin T, Liang H, Zhang Z, He S, Tu Y, Yang H, Geng T, Cui G, Chen C, Gao G (2013) RTEL1 tagging SNPs and haplotypes were associated with glioma development. Diagn Pathol 8:83. doi:10.1186/1746-1596-8-83

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Jin TB, Zhang JY, Li G, Du SL, Geng TT, Gao J, Liu QP, Gao GD, Kang LL, Chen C, Li SQ (2013) RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population. Tumour Biol 34:3659–3666. doi:10.1007/s13277-013-0947-0

    Article  CAS  PubMed  Google Scholar 

  37. Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108:11–27. doi:10.1007/s11060-011-0793-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507. doi:10.1056/NEJMra0708126

    Article  CAS  PubMed  Google Scholar 

  39. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O’Neill BP, Buckner JC, Il’yasova D, Jenkins RB, Wrensch MR (2011) Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 174:574–581. doi:10.1093/aje/kwr124

    Article  PubMed  PubMed Central  Google Scholar 

  40. Chi J, Gu B, Zhang C, Peng GY, Zhou F, Chen Y, Zhang GF, Guo YD, Guo DD, Qin J, Wang JF, Li LY, Wang F, Liu GY, Xie FY, Feng DJ, Zhou H, Huang XX, Lu SQ, Liu YX, Hu WX, Yao K (2012) Human herpesvirus 6 latent infection in patients with glioma. J Infect Dis 206:1394–1398. doi:10.1093/infdis/jis513

    Article  CAS  PubMed  Google Scholar 

  41. Crawford JR, Santi MR, Thorarinsdottir HK, Cornelison R, Rushing EJ, Zhang HZ, Yao K, Jacobson S, MacDonald TJ (2009) Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 46:37–42. doi:10.1016/j.jcv.2009.05.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il’yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy M (2007) GLIOGENE—an international consortium to understand familial glioma. Cancer Epidemiol Biomark Prev 16:1730–1734. doi:10.1158/1055-9965.EPI-07-0081

    Article  CAS  Google Scholar 

  43. Melin B, Dahlin AM, Andersson U, Wang Z, Henriksson R, Hallmans G, Bondy ML, Johansen C, Feychting M, Ahlbom A, Kitahara CM, Wang SS, Ruder AM, Carreon T, Butler MA, Inskip PD, Purdue M, Hsing AW, Mechanic L, Gillanders E, Yeager M, Linet M, Chanock SJ, Hartge P, Rajaraman P (2013) Known glioma risk loci are associated with glioma with a family history of brain tumours—a case-control gene association study. Int J Cancer 132:2464–2468. doi:10.1002/ijc.27922

    Article  CAS  PubMed  Google Scholar 

  44. Das BR, Tangri R, Ahmad F, Roy A, Patole K (2013) Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients. Asian Pac J Cancer Prev 14:7261–7264. doi:10.7314/Apjcp.2013.14.12.7261

    Article  PubMed  Google Scholar 

  45. Lin J, Kou Y (2014) Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4136 cases and 5233 controls. Tumour Biol 35:425–432. doi:10.1007/s13277-013-1059-6

    Article  CAS  PubMed  Google Scholar 

  46. Labussiere M, Di Stefano AL, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston RS, Hoang-Xuan K, Idbaih A, Delattre JY, Mokhtari K, Sanson M (2014) TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br J Cancer 111:2024–2032. doi:10.1038/bjc.2014.538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Barber LJ, Youds JL, Ward JD, McIlwraith MJ, O’Neil NJ, Petalcorin MIR, Martin JS, Collis SJ, Cantor SB, Auclair M, Tissenbaum H, West SC, Rose AM, Boulton SJ (2008) RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261–271. doi:10.1016/j.cell.2008.08.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ballew BJ, Joseph V, De S, Sarek G, Vannier JB, Stracker T, Schrader KA, Small TN, O’Reilly R, Manschreck C, Harlan Fleischut MM, Zhang L, Sullivan J, Stratton K, Yeager M, Jacobs K, Giri N, Alter BP, Boland J, Burdett L, Offit K, Boulton SJ, Savage SA, Petrini JH (2013) A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet 9:e1003695. doi:10.1371/journal.pgen.1003695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Deng Z, Glousker G, Molczan A, Fox AJ, Lamm N, Dheekollu J, Weizman OE, Schertzer M, Wang Z, Vladimirova O, Schug J, Aker M, Londono-Vallejo A, Kaestner KH, Lieberman PM, Tzfati Y (2013) Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci USA 110:E3408–E3416. doi:10.1073/pnas.1300600110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weiqiang Huang.

Ethics declarations

Conflict of interest

No competing financial interests exist.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, C., Lu, Y., Zhang, X. et al. The role of the RTEL1 rs2297440 polymorphism in the risk of glioma development: a meta-analysis. Neurol Sci 37, 1023–1031 (2016). https://doi.org/10.1007/s10072-016-2531-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2531-z

Keywords

Navigation